@book{85403493d8064b51ad7e2276d7cd3efe,
title = "Regulation of biopharmaceuticals, tissue engineering and biogenerics: Key issues for the developer",
keywords = "Biopharmaceuticals, regulation, EMEA, FDA, tissue engineering, biogeneric, risk management, Biopharmaceuticals, regulation, EMEA, FDA, tissue engineering, biogeneric, risk management, Biopharmaceuticals, regulation, EMEA, FDA, tissue engineering, biogeneric, risk management",
author = "Outi Oila",
year = "2005",
language = "English",
publisher = "Unknown Publisher",
}